REJUVENATE BIO
Rejuvenate Bio is a biotechnology company that develops novel gene therapies for dogs. The company's therapy provides a solution for the mitral valve disease to stop the progression of heart failure in dogs, thus providing pets with extended overall health and maximal lifespan. It was founded in 2017 and is based in San Diego, CA.
REJUVENATE BIO
Industry:
Animal Feed Biotechnology Health Care
Founded:
2017-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.rejuvenatebio.com
Total Employee:
11+
Status:
Active
Contact:
858-381-3462
Email Addresses:
[email protected]
Total Funding:
17.1 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API LetsEncrypt Content Delivery Network Euro Squarespace Squarespace Add To Cart
Similar Organizations
AnimalBiome
AnimalBiome is a biotechnology company that creates microbiome restorative supplements to dogs and cats.
Rakuten Medical
Rakuten Medical is a Bio-technology Company.
Aura Biosciences
Aura Biosciences is a biotechnology company that focuses on the development of drugs by using tumor targeted pseudovirions.
Day One Biopharmaceuticals
Day One Biopharmaceuticals is a biotechnology company that focuses on developing new cancer therapies for patients of all ages.
ElevateBio
ElevateBio is a biotechnology company that specializes in cell and gene-based therapies.
Gallant Pet
Gallant Pet is a pet service company that develops a stem cell therapy intended for dog wounds.
Kindred Biosciences
Kindred Biosciences is a veterinary biotechnology company that focuses on developing therapies for dogs, cats and horses.
Ikena Oncology
Ikena Oncology is a biotechnology company that advances new immunometabolic therapies for cancer.
Novellus
Novellus is a biotechnology company working to develop engineered cellular medicines.
Remix Therapeutics
Remix Therapeutics is a biotechnology company.
Vigil Neuroscience
Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.
Vor Biopharma
Vor Biopharma is an immuno-oncology company that develops therapies for treating cancer.
Current Employees Featured
Founder
Investors List
VCapital
VCapital investment in Series A - Rejuvenate Bio
Companion Fund
Companion Fund investment in Seed Round - Rejuvenate Bio
Digitalis Ventures
Digitalis Ventures investment in Seed Round - Rejuvenate Bio
KdT Ventures
KdT Ventures investment in Seed Round - Rejuvenate Bio
Official Site Inspections
http://www.rejuvenatebio.com Semrush global rank: 1.52 M Semrush visits lastest month: 17.43 K
- Host name: 198.49.23.145
- IP address: 198.49.23.145
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013
More informations about "Rejuvenate Bio"
Rejuvenate Bio
Creating ideal treatments to address the 6 in 10 Americans that suffer from a chronic disease. Six in ten Americans live with at least one chronic disease. These and other chronic diseases are …See details»
Team - Rejuvenate Bio
At Rejuvenate Bio, we are developing novel therapies to treat aging and age-related diseases through innovative targeted gene therapies. We launched out of George Church's lab at …See details»
Rejuvenate Bio - Crunchbase Company Profile & Funding
Rejuvenate Bio is a biotechnology company that develops therapies to reverse aging and treat age-related diseases. Rejuvenate Bio announced that its gene therapy-mediated partial reprogramming extends lifespan and reverses age …See details»
Rejuvenate Bio Company Profile 2024: Valuation, …
Developer of a gene therapy platform designed to reverse pre-existing heart disease, metabolic disease and kidney failure in humans. The company's platform provides a way for mitral valve disease to stop the progression as well as …See details»
General 4 — Rejuvenate Bio
Utilization of liver tropic capsids encoding for secreted proteins minimize dose while delivering therapeutic protein to high percentage of target cells. Ensuring sustained, durable efficacy for …See details»
Rejuvenate Bio Receives $4M in Funding from the …
SAN DIEGO, July 01, 2024 -- (BUSINESS WIRE)-- Rejuvenate Bio, announced today that the California Institute for Regenerative Medicine (CIRM) has awarded the company a $4M grant to complete...See details»
Rejuvenate Bio - LinkedIn
Rejuvenate Bio is targeting the core drivers of chronic age-related diseases by unlocking the power of gene expression and epigenetic reprogramming to reverse pre-existing heart disease,...See details»
Rejuvenate Bio Announces Data for Gene Therapy RJB …
May 18, 2023 · Rejuvenate Bio is a spinout from the Wyss Institute at Harvard focused on reversing aging and eliminating age-related disease. Rejuvenate Bio utilizes gene therapy, proprietary targets, and...See details»
Rejuvenate Bio Announces New Preclinical Research Evaluating …
Jan 9, 2023 · SAN DIEGO-- (BUSINESS WIRE)-- Rejuvenate Bio, today announced new preclinical research published to the preprint server bioRxiv, that evaluates how partial …See details»
Rejuvenate Bio banks $10M to advance gene therapy …
Apr 19, 2021 · Rejuvenate Bio’s treatment is a gene therapy that dials up expression of the genes sTGFbetaR2 and FGF21 to reduce levels of the cytokine TGF-beta1 and boost levels of the hormone FGF21,...See details»
Rejuvenate Bio Launches New Office in San Diego
Nov 7, 2022 · Rejuvenate Bio is a spinout from the Wyss Institute at Harvard focused on reversing aging and eliminating age-related disease. Rejuvenate Bio utilizes gene therapy, proprietary targets, and tools...See details»
Gene Therapy-Mediated Partial Reprogramming Extends Lifespan …
Aging is a complex progression of changes best characterized as the chronic dysregulation of cellular processes leading to deteriorated tissue and organ function. Although aging cannot …See details»
Rejuvenate Bio Announces Gene Therapy-Mediated Partial …
Feb 22, 2024 · Rejuvenate Bio's research focuses on partial reprogramming using the Yamanaka factors, specifically OCT4, SOX2, and KLF4 (OSK), to reverse age-related changes.See details»
Rejuvenate Bio Raises Over $10M in Series A Funding for Gene …
Apr 19, 2021 · Rejuvenate Bio announced today that it has raised over $10 million in a Series A funding round led by Kendall Capital Partners, a Boston-based firm focused on early-stage …See details»
Rejuvenate Bio Announces Partnership with Leading Animal …
SAN DIEGO, February 14, 2024 -- (BUSINESS WIRE)-- Rejuvenate Bio today announced a partnership with a leading animal health company for the development and commercialization …See details»
Phibro Animal Health Corporation and Rejuvenate Bio Announce …
Jun 22, 2022 · TEANECK, N.J.-- ( BUSINESS WIRE )--Phibro Animal Health Corporation (Nasdaq:PAHC) and Rejuvenate Bio, Inc. today announced a collaboration for the …See details»
In the News - Rejuvenate Bio
Nov 30, 2021 · “The launch of our new office in this leading biotech hub allows us to aggressively pursue our business development and leverage the talent and expertise San Diego offers,” …See details»
Rejuvenate Bio - Facebook
Rejuvenate Bio. 941 likes. A SOLUTION FOR MITRAL VALVE DISEASE Novel gene therapies for dogs Because your dog deserves to live its best life.See details»
General 4 — Rejuvenate Bio
RJB-0402 . Liver directed gene therapy delivering FGF21. Home Page. Our Science. Pipeline. Press Releases. In the News. Terms & ConditionsSee details»
Blog 3 — Rejuvenate Bio
Nov 7, 2022 · Rejuvenate Bio announced today that it has raised over $10 million in a Series A funding round led by Kendall Capital Partners, a Boston-based firm focused on early-stage …See details»